US: Meeting Held to Discuss Delay of Banning Menthol Cigarettes

Regulations by 2FIRSTS.ai
Dec.21.2023
US: Meeting Held to Discuss Delay of Banning Menthol Cigarettes
US government officials and public health leaders held a meeting to discuss the delayed ban on menthol cigarettes.

According to a report by thehill, there has been a recent meeting between US government officials and public health leaders. This meeting took place following the US government's decision to delay the ban on flavored menthol cigarettes.

 

The meeting, which was not publicly announced, was not officially included in the public agenda. However, government officials had previously held a meeting with tobacco industry lobbyists, including some former senators, last month, in opposition to the proposed ban. Two weeks later, the White House officially announced that the ban would be postponed until at least March.

 

The online conference held this Tuesday, initiated by the "Smoke-Free Youth" campaign, was attended by officials including Robert Califf, the Commissioner of the U.S. Food and Drug Administration (FDA), Xavier Becerra, the Secretary of Health and Human Services (HHS), and Neera Tanden, the White House Domestic Policy Advisor.

 

According to feedback from attendees, the organization of the meeting took place after the announcement of the delay in the ban, during which public health officials questioned industry lobbyists on the reasons behind their ability to meet with senior government officials.

 

In attendance among public health and civil rights leaders were Derrick Johnson, President and CEO of the National Association for the Advancement of Colored People (NAACP); David Satcher, former advocate for disease prevention and the first African American Surgeon General of the United States; Louis Sullivan, former Secretary of the U.S. Department of Health and Human Services (HHS); Yolanda Lawson, Chair of the American Medical Association; as well as board leaders from the American Cancer Society Cancer Action Network, the American Lung Association, and the American Heart Association.

 

The Office of Management and Budget (OMB), which is responsible for regulatory actions, needs to hold meetings with stakeholders interested in the proposed regulations. These meetings are held to gather opinions and are typically not attended by senior officials.

 

Since October, the OMB has held multiple meetings with external organizations regarding policies, including retailers, civil rights groups, and law enforcement officials. According to records, nearly all of the meetings have been with organizations opposed to the ban.

 

The public health organization has been warning that the White House may under pressure decide to indefinitely delay the regulation, especially against the backdrop of Joe Biden's reelection bid as president.

 

According to the initially planned schedule, the new regulations were supposed to be released in August, but were later postponed until the end of the year. As part of its regulatory plan, the White House has now set a new target date for March 2024.

 

The ban on menthol cigarettes has been under consideration for more than a decade and, once implemented, will be one of the most impactful policies since the US FDA began regulating tobacco in 2009. Health officials and tobacco control advocates have stated that this action could potentially save thousands of lives, particularly among African American smokers.

 

According to an FDA report, approximately 85% of African American smokers prefer menthol cigarettes, compared to only 30% among white smokers.

 

However, the proposal of the ban has sparked disagreement among some influential black lawmakers and community members. Critics argue that this foreshadows a longstanding industry practice aimed at targeting black communities and forming alliances with leaders to create chaos.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives
Gallery | InterTabac 2026 Opens as VAPORESSO, SKE, GREENTANK, GEEK BAR and Other Brands Take the Floor
Gallery | InterTabac 2026 Opens as VAPORESSO, SKE, GREENTANK, GEEK BAR and Other Brands Take the Floor
InterTabac 2026 opened in Dortmund, Germany, on September 15 alongside NUBIZ and InterSupply. According to the latest figures released by the organizer, the three trade shows bring together around 750 exhibitors from 64 countries. On site, 2Firsts observed vaping and related brands including VAPORESSO, DOJO, SKE, GREENTANK, GEEK BAR, HQD and ELUX.
Special Report
Sep.15
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
The House-passed FY2027 National Defense Authorization Act includes a provision authorizing the defense secretary to conduct a one-year smoking-cessation pilot for active-duty service members. Section 707 lists counseling, nicotine gum and patches alongside what the bill calls "electric nicotine delivery systems," nicotine pouches and heat-not-burn products. A recent Washington Examiner op-ed cited ZYN as an example in arguing for the provision, but the legislation does not name any commercial brand or supplier. ZYN is made by PMI-owned Swedish Match USA, with specified products holding FDA marketing authorizations and modified risk orders.
Sep.20
BAT’s Velo Study Finds 61% of Nicotine Users Feel More Comfortable Expressing Themselves When Others Do the Same
BAT’s Velo Study Finds 61% of Nicotine Users Feel More Comfortable Expressing Themselves When Others Do the Same
British American Tobacco’s (BAT) nicotine pouch brand Velo has released a global consumer study and launched its “Echoes of Tomorrowland” campaign with electronic music festival brand Tomorrowland. The research surveyed 2,009 nicotine users across the UK, Spain, Pakistan, Poland and Austria. Velo said 61% of respondents feel more comfortable expressing themselves when they see others doing the same, while 39% said building meaningful connections becomes harder with age. The campaign reflects how nicotine pouch brands are increasingly using music, communities and lifestyle marketing to build consumer engagement.
Aug.10
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26